NASDAQ:AXNX - Axonics Modulation Technologies Stock Price, News, & Analysis

$35.93
+1.33 (+3.84 %)
(As of 06/18/2019 09:10 AM ET)
Today's Range
$34.71
Now: $35.93
$36.93
50-Day Range
$20.20
MA: $29.85
$36.03
52-Week Range
$11.95
Now: $35.93
$36.93
Volume235,123 shs
Average Volume185,277 shs
Market Capitalization$1.02 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Axonics Modulation Technologies, Inc., a medical technology company, focuses on the design, development, and commercialization of sacral neuromodulation solutions (SNM) solutions. The SNM therapy is primarily used to treat patients with overactive bladder, including urinary urgency incontinence and urinary urgency frequency, fecal incontinence, and urinary retention. Its proprietary r-SNM System delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of urinary and fecal dysfunction. The company was formerly known as American Restorative Medicine, Inc. and changed its name to Axonics Modulation Technologies, Inc. in August 2013. Axonics Modulation Technologies, Inc. was founded in 2012 and is based in Irvine, California.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AXNX
CUSIPN/A
CIKN/A
Phone949-396-6322

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$710,000.00
Book Value$5.15 per share

Profitability

Miscellaneous

Employees87
Market Cap$1.02 billion
Next Earnings Date8/14/2019 (Estimated)
OptionableNot Optionable

Receive AXNX News and Ratings via Email

Sign-up to receive the latest news and ratings for AXNX and its competitors with MarketBeat's FREE daily newsletter.

Axonics Modulation Technologies (NASDAQ:AXNX) Frequently Asked Questions

What is Axonics Modulation Technologies' stock symbol?

Axonics Modulation Technologies trades on the NASDAQ under the ticker symbol "AXNX."

How were Axonics Modulation Technologies' earnings last quarter?

Axonics Modulation Technologies Inc (NASDAQ:AXNX) posted its earnings results on Wednesday, May, 8th. The company reported ($0.47) EPS for the quarter, missing the consensus estimate of ($0.40) by $0.07. The company earned $1.08 million during the quarter, compared to analysts' expectations of $0.53 million. View Axonics Modulation Technologies' Earnings History.

When is Axonics Modulation Technologies' next earnings date?

Axonics Modulation Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, August 14th 2019. View Earnings Estimates for Axonics Modulation Technologies.

What price target have analysts set for AXNX?

4 equities research analysts have issued 1 year price objectives for Axonics Modulation Technologies' stock. Their predictions range from $14.92 to $35.00. On average, they anticipate Axonics Modulation Technologies' share price to reach $26.23 in the next year. This suggests that the stock has a possible downside of 27.0%. View Analyst Price Targets for Axonics Modulation Technologies.

What is the consensus analysts' recommendation for Axonics Modulation Technologies?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axonics Modulation Technologies in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Axonics Modulation Technologies.

Has Axonics Modulation Technologies been receiving favorable news coverage?

News coverage about AXNX stock has trended negative recently, according to InfoTrie. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Axonics Modulation Technologies earned a media sentiment score of -2.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Axonics Modulation Technologies.

Are investors shorting Axonics Modulation Technologies?

Axonics Modulation Technologies saw a decrease in short interest in the month of May. As of May 15th, there was short interest totalling 1,207,700 shares, a decrease of 17.1% from the April 15th total of 1,457,500 shares. Based on an average daily trading volume, of 129,500 shares, the days-to-cover ratio is currently 9.3 days. Currently, 7.4% of the shares of the company are sold short. View Axonics Modulation Technologies' Current Options Chain.

Who are some of Axonics Modulation Technologies' key competitors?

What other stocks do shareholders of Axonics Modulation Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axonics Modulation Technologies investors own include Oasis Petroleum (OAS), Intrexon (XON), Camping World (CWH), PagSeguro Digital (PAGS), US Xpress Enterprises (USX), MEI Pharma (MEIP), Dresser-Rand Group (DRC), Achieve Life Sciences (ACHV), Cyberark Software (CYBR) and Auris Medical (EARS).

Who are Axonics Modulation Technologies' key executives?

Axonics Modulation Technologies' management team includes the folowing people:
  • Mr. Raymond W. Cohen, CEO & Director (Age 60)
  • Mr. Danny L. Dearen, Pres & CFO (Age 56)
  • Dr. Karen L. Noblett M.D., M.A.S., Chief Medical Officer (Age 56)
  • Mr. Rinda K. Sama, Chief Operating Officer (Age 40)
  • Mr. Guangqiang Jiang Ph.D., Chief Technology Officer (Age 46)

When did Axonics Modulation Technologies IPO?

(AXNX) raised $100 million in an IPO on Wednesday, October 31st 2018. The company issued 6,700,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Morgan Stanley served as the underwriters for the IPO and Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

When did Axonics Modulation Technologies' lock-up period expire?

Axonics Modulation Technologies' lock-up period expired on Monday, April 29th. Axonics Modulation Technologies had issued 8,000,000 shares in its initial public offering on October 31st. The total size of the offering was $120,000,000 based on an initial share price of $15.00. Since the expiration of Axonics Modulation Technologies' lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Who are Axonics Modulation Technologies' major shareholders?

Axonics Modulation Technologies' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include FMR LLC (4.01%), Redmile Group LLC (2.12%), JPMorgan Chase & Co. (0.83%), EAM Global Investors LLC (0.22%), Granite Investment Partners LLC (0.13%) and Brightworth (0.04%). Company insiders that own Axonics Modulation Technologies stock include Bakker Juliet Tammenoms, Cormorant Asset Management, Lp, Healthcare Holding BV Gilde and Rinda Sama. View Institutional Ownership Trends for Axonics Modulation Technologies.

Which major investors are selling Axonics Modulation Technologies stock?

AXNX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Redmile Group LLC and JPMorgan Chase & Co.. View Insider Buying and Selling for Axonics Modulation Technologies.

Which major investors are buying Axonics Modulation Technologies stock?

AXNX stock was acquired by a variety of institutional investors in the last quarter, including EAM Global Investors LLC, Granite Investment Partners LLC, Brightworth and Westfield Capital Management Co. LP. Company insiders that have bought Axonics Modulation Technologies stock in the last two years include Bakker Juliet Tammenoms, Cormorant Asset Management, Lp and Healthcare Holding BV Gilde. View Insider Buying and Selling for Axonics Modulation Technologies.

How do I buy shares of Axonics Modulation Technologies?

Shares of AXNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Axonics Modulation Technologies' stock price today?

One share of AXNX stock can currently be purchased for approximately $35.93.

How big of a company is Axonics Modulation Technologies?

Axonics Modulation Technologies has a market capitalization of $1.02 billion and generates $710,000.00 in revenue each year. The company earns $-32,480,000.00 in net income (profit) each year or ($4.64) on an earnings per share basis. Axonics Modulation Technologies employs 87 workers across the globe.View Additional Information About Axonics Modulation Technologies.

What is Axonics Modulation Technologies' official website?

The official website for Axonics Modulation Technologies is http://www.axonicsmodulation.com/.

How can I contact Axonics Modulation Technologies?

Axonics Modulation Technologies' mailing address is 26 TECHNOLOGY DRIVE, IRVINE CA, 92618. The company can be reached via phone at 949-396-6322.


MarketBeat Community Rating for Axonics Modulation Technologies (NASDAQ AXNX)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  28 (Vote Underperform)
Total Votes:  53
MarketBeat's community ratings are surveys of what our community members think about Axonics Modulation Technologies and other stocks. Vote "Outperform" if you believe AXNX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AXNX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/18/2019 by MarketBeat.com Staff

Featured Article: Forex

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel